If you need more lookups,
subscriptions start at $34 USD/month.
Paul Maffuid Location
San Diego, CA, US
Paul Maffuid Work
2023 -now Chief Scientific Officer @
2022 -now President @ Biopharmalogics, Inc
2022 -now Chief Development Officer @ Aayam Therapeutics, Inc.
2020 -2022 Chief Executive Officer @ Sphaera Pharma Inc.
2014 -2020 Vice President Pharmaceutical Development @
2011 -2014 Executive Vice President, Operations @
2001 -2008 Vice President, Pharmaceutical Development @
2000 -2001 Executive Director, Structural Chemistry @ Magellan Laboratories, Inc.
1998 -2000 Executive Director, Pharmaceutical Development @ Cabrillo Laboratories
1994 -1998 Director, Pharmaceutical Development @
1990 -1994 Research Investigator, Structural Chemistry @ Glaxo Research Institute
1987 -1987 Senior Research Associate, Drug Delivery @ California Biotechnology
1985 -1987 Chemist III @ Syntex Corporation
1981 -1985 Staff Research Associate III @
Paul Maffuid Education
UC San Diego
Ph.D. (Organic Chemistry)
Paul Maffuid Skills
Drug Development
Chemistry
Formulation
Drug Delivery
Pharmaceutics
Drug Discovery
Mass Spectrometry
Pharmacology
Analytical Chemistry
GMP
Pharmaceutical Industry
FDA
GLP
CRO
Biopharmaceuticals
HPLC
Biotechnology
Regulatory Affairs
Validation
Sop
Technology Transfer
Chromatography
Strategic Planning
Organic Chemistry
Business Development
Strategy
Microsoft Excel
u.s. Food and Drug Administration Fda
u.s. Food and Drug Administration
Paul Maffuid Summary
Paul Maffuid, based in San Diego, CA, US, is currently a Chief Scientific Officer at Med Aditus. Paul Maffuid brings experience from previous roles at Biopharmalogics, Inc, Aayam Therapeutics, Inc., Sphaera Pharma Inc. and MabVax Therapeutics, Inc.. Paul Maffuid holds a Ph.D. in Organic Chemistry @ UC San Diego. With a robust skill set that includes Drug Development, Chemistry, Formulation, Drug Delivery, Pharmaceutics and more. Paul Maffuid has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Paul Maffuid?
Find contact details for 700 million professionals.